ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Revenue ContractionContracting
Percentile Rank47
3Y CAGR+6.8%
5Y CAGR+12.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+6.8%/yr
vs +2.6%/yr prior
5Y CAGR
+12.5%/yr
Recent deceleration
Acceleration
+4.2pp
Accelerating
Percentile
P47
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$8.11B-12.0%
2025$9.22B+12.6%
2024$8.19B+23.0%
2023$6.66B+19.0%
2022$5.60B+24.3%
2021$4.50B-7.0%
2020$4.84B-19.4%
2019$6.00B-12.2%
2018$6.83B-14.3%
2017$7.97B-